BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 8855941)

  • 21. The amino acids that constitute sequence gamma 268-282 of fibrinogen are not involved in fibrin monomer polymerization.
    Janiak A; Plucinski T; Kupryszewski G; Cierniewski CS
    Acta Biochim Pol; 1993; 40(4):515-20. PubMed ID: 8140826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
    Jani M; Tordai H; Trexler M; Bányai L; Patthy L
    Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxyapatite induces autolytic degradation and inactivation of matrix metalloproteinase-1 and -3.
    Kremer EA; Chen Y; Suzuki K; Nagase H; Gorski JP
    J Bone Miner Res; 1998 Dec; 13(12):1890-902. PubMed ID: 9844107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.
    Spraggon G; Everse SJ; Doolittle RF
    Nature; 1997 Oct; 389(6650):455-62. PubMed ID: 9333233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive exposure of E-neoantigen associated with degradation of crosslinked fibrin by plasmin in vitro.
    Stegnar M; Chen JP
    Thromb Haemost; 1984 Dec; 52(3):315-20. PubMed ID: 6241755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degradation of interleukin 1beta by matrix metalloproteinases.
    Ito A; Mukaiyama A; Itoh Y; Nagase H; Thogersen IB; Enghild JJ; Sasaguri Y; Mori Y
    J Biol Chem; 1996 Jun; 271(25):14657-60. PubMed ID: 8663297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markers of fibrinogen derivatives used in clinical investigation.
    Soria J; Soria C; Mirshahi M; Samama MM
    Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.
    Yoshida N; Terukina S; Okuma M; Moroi M; Aoki N; Matsuda M
    J Biol Chem; 1988 Sep; 263(27):13848-56. PubMed ID: 2971046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain.
    Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ
    Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
    Brenner B; Francis CW; Marder VJ
    J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The antifibrinolytic action of the D-dimer fragment].
    Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
    Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Action of proteolytic enzymes on fibrinogen].
    Jamet M; Levy G
    Ann Anesthesiol Fr; 1978; 19(8):687-91. PubMed ID: 31111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilianii.
    Malinconico SM; Katz JB; Budzynski AZ
    J Lab Clin Med; 1984 Nov; 104(5):842-54. PubMed ID: 6387015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degradation of cross-linked fibrin by human leukocyte proteases.
    Francis CW; Marder VJ
    J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of urinary protein C inhibitor to fibrin(ogen) and its binding mechanism.
    Hayashi S; Yamada K
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):153-8. PubMed ID: 8384496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cleavage sequence of fibrinopeptide A from fibrinogen fragment E by thrombin, atroxin or batroxobin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):107-12. PubMed ID: 8457636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Availability of the B beta(15-21) epitope on cross-linked human fibrin and its plasmic degradation products.
    Chen F; Haber E; Matsueda GR
    Thromb Haemost; 1992 Mar; 67(3):335-40. PubMed ID: 1379385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of native matrix metalloproteinases and their recombinant catalytic domains using a novel radiometric assay.
    Brownell J; Earley W; Kunec E; Morgan BA; Olyslager B; Wahl RC; Houck DR
    Arch Biochem Biophys; 1994 Oct; 314(1):120-5. PubMed ID: 7944383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway.
    Makowski GS; Ramsby ML
    Inflammation; 1998 Jun; 22(3):287-305. PubMed ID: 9604716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.